Understanding the immune environment in specific cancer types
Spatial characterization of the tumor-immune microenvironment in SMARCB1-deficient epithelioid sarcomas
This study is looking at how certain tumors, specifically a type called SMARCB1-deficient epithelioid sarcomas, interact with the immune system to understand why some don’t respond well to current treatments, with the hope of finding better ways to help patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sloan-Kettering Inst Can Research NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11074769 on NIH RePORTER |
What this research studies
This research investigates how tumors interact with the immune system, particularly in cases of SMARCB1-deficient epithelioid sarcomas. By using advanced techniques like machine learning and spatial transcriptomics, the team aims to analyze the immune microenvironments of these tumors. The goal is to identify why some cancers do not respond to current immunotherapies and to develop new strategies to enhance treatment effectiveness. Patients may benefit from insights that could lead to improved therapies tailored to their specific cancer type.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with SMARCB1-deficient epithelioid sarcomas.
Not a fit: Patients with cancers not related to SMARCB1 deficiency may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective immunotherapy options for patients with difficult-to-treat cancers.
How similar studies have performed: Other research has shown promise in understanding tumor-immune interactions, but this specific approach is novel and aims to address gaps in current immunotherapy effectiveness.
Where this research is happening
New York, United States
- Sloan-Kettering Inst Can Research — New York, United States (Active)
Researchers
- Principal investigator: Leslie, Christina S — Sloan-Kettering Inst Can Research
- Study coordinator: Leslie, Christina S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.